Clarifying CB2 receptor-dependent and independent effects of THC on human lung epithelial cells

Toxicology and Applied Pharmacology

Volumn 231, Issue 3, 2008, Pages 282-290

  Sarafian, Theodore ^a   Montes, Cindy ^a   Harui, Airi ^a   Beedanagari, Sudheer R ^a   Kiertscher, Sylvia ^a   Stripecke, Renata ^a   Hossepian, Derik ^a   Kitchen, Christina ^b   Kern, Rita ^a   Belperio, John ^a   Roth, Michael D ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cannabinoid receptor; Chemotaxis; Lentiviral vector; MAPK signaling; Mitochondria; Tetrahydrocannabinol (THC)

Indexed keywords

5 (4 CHLORO 3 METHYLPHENYL) 1 (4 METHYLBENZYL) N (1,3,3 TRIMETHYLBICYCLO[2.2.1]HEPTAN 2 YL) 3 PYRAZOLECARBOXAMIDE; ADENOSINE TRIPHOSPHATE; CANNABINOID 2 RECEPTOR; CANNABINOID RECEPTOR ANTAGONIST; CANNABIS; CYCLOSPORIN A; DRONABINOL; I KAPPA B ALPHA; LENTIVIRUS VECTOR; MESSENGER RNA; STRESS ACTIVATED PROTEIN KINASE; TETRAHYDROCANNABINOL;

ARTICLE; CANNABIS SMOKING; CELL ENERGY; CELL FUNCTION; CELL MIGRATION; CHEMOTAXIS; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; LUNG ALVEOLUS EPITHELIUM; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; TOBACCO;

CELL LINE; DOSE-RESPONSE RELATIONSHIP, DRUG; EPITHELIAL CELLS; HUMANS; LUNG; MARIJUANA SMOKING; RECEPTOR, CANNABINOID, CB2; RESPIRATORY MUCOSA; SIGNAL TRANSDUCTION; TETRAHYDROCANNABINOL;

CANNABIS SATIVA; NICOTIANA TABACUM;

EID: 50849138845     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2008.05.001     Document Type: Article

References (59)

1. Adams I.B., and Martin B.R. Cannabis: pharmacology and toxicology in animals and humans. Addiction 91 (1996) 1585-1614
2. Aldington S., Williams M., Nowitz M., Weatherall M., Pritchard A., McNaughton A., Robinson G., and Beasley R. The effects of Cannabis on pulmonary structure, function and symptoms. Thorax 62 (2007) 1058-1063
3. Baldwin G.C., Tashkin D.P., Buckley D.M., Park A.N., Dubinett S.M., and Roth M.D. Marijuana and cocaine impair alveolar macrophage function and cytokine production. Am. J. Respir. Crit. Care Med. 156 (1997) 1606-1613
4. Barsky S.H., Roth M.D., Kleerup E.C., Simmons M., and Tashkin D.P. Histopathologic and molecular alterations in bronchial epithelium in habitual smokers of marijuana, cocaine, and/or tobacco. J. Natl. Cancer Inst. 90 (1998) 1198-1205
5. Campello S., Lacalle R.A., Bettella M., Manes S., Scorrano L., and Viola A. Orchestration of lymphocyte chemotaxis by mitochondrial dynamics. J. Exp. Med. 203 (2006) 2879-2886
6. Cantral D.E., Sisson J.H., Veys T., Rennard S.I., and Spurzem J.R. Effects of cigarette smoke extract on bovine bronchial epithelial cell attachment and migration. Am. J. Physiol. 268 (1995) L723-L728
7. Chen Y., Corriden R., Inoue Y., Yip L., Hashiguchi N., Zinkernagel A., Nizet V., Insel P.A., and Junger W.G. ATP release guides neutrophil chemotaxis via P2Y2 and A3 receptors. Science 314 (2006) 1792-1795
8. Christensen P.J., Du M., Moore B., Morris S., Toews G.B., and Paine III R. Expression and functional implications of CCR2 expression on murine alveolar epithelial cells. Am. J. Physiol., Lung Cell. Mol. Physiol. 286 (2004) L68-L72
9. Coopman K., Smith L.D., Wright K.L., and Ward S.G. Temporal variation in CB2R levels following T lymphocyte activation: evidence that cannabinoids modulate CXCL12-induced chemotaxis. Int. Immunopharmacol. 7 (2007) 360-371
10. Demuth D.G., and Molleman A. Cannabinoid signalling. Life Sci. 78 (2006) 549-563
11. Di Luozzo G., Pradhan S., Dhadwal A.K., Chen A., Ueno H., and Sumpio B.E. Nicotine induces mitogen-activated protein kinase dependent vascular smooth muscle cell migration. Atherosclerosis 178 (2005) 271-277
12. Ghosh S., Preet A., Groopman J.E., and Ganju R.K. Cannabinoid receptor CB2 modulates the CXCL12/CXCR4-mediated chemotaxis of T lymphocytes. Mol. Immunol. 43 (2006) 2169-2179
13. Griffin G., Tao Q., and Abood M.E. Cloning and pharmacological characterization of the rat CB(2) cannabinoid receptor. J. Pharmacol. Exp. Ther. 292 (2000) 886-894
14. Hashibe M., Straif K., Tashkin D.P., Morgenstern H., Greenland S., and Zhang Z.F. Epidemiologic review of marijuana use and cancer risk. Alcohol 35 (2005) 265-275
15. Howlett A.C. Cannabinoid receptor signaling. Handb. Exp. Pharmacol. (2005) 53-79
16. Johnston L.D., O'Malley P., Bachman J.G., and Schulenberg J.E. Monitoring the Future: National Survey Results on Drug Use, 1975-2001 (2006), U.S. Department of Health and Human Services I.
17. Jorda M.A., Verbakel S.E., Valk P.J., Vankan-Berkhoudt Y.V., Maccarrone M., Finazzi-Agro A., Lowenberg B., and Delwel R. Hematopoietic cells expressing the peripheral cannabinoid receptor migrate in response to the endocannabinoid 2-arachidonoylglycerol. Blood 99 (2002) 2786-2793
18. Joseph J., Niggemann B., Zaenker K.S., and Entschladen F. Anandamide is an endogenous inhibitor for the migration of tumor cells and T lymphocytes. Cancer Immunol. Immunother. 53 (2004) 723-728
19. Kearn C.S., Blake-Palmer K., Daniel E., Mackie K., and Glass M. Concurrent stimulation of cannabinoid CB1 and dopamine D2 receptors enhances heterodimer formation: a mechanism for receptor cross-talk?. Mol. Pharmacol. 67 (2005) 1697-1704
20. Kishimoto S., Muramatsu M., Gokoh M., Oka S., Waku K., and Sugiura T. Endogenous cannabinoid receptor ligand induces the migration of human natural killer cells. J. Biochem. (Tokyo) 137 (2005) 217-223
21. Klein T.W. Cannabinoid-based drugs as anti-inflammatory therapeutics. Nat. Rev. Immunol. 5 (2005) 400-411
22. Lu T., Newton C., Perkins I., Friedman H., and Klein T.W. Role of cannabinoid receptors in Delta-9-tetrahydrocannabinol suppression of IL-12p40 in mouse bone marrow-derived dendritic cells infected with Legionella pneumophila. Eur. J. Pharmacol. 532 (2006) 170-177
23. Maccarrone M. Fatty acid amide hydrolase: a potential target for next generation therapeutics. Curr. Pharm. Des. 12 (2006) 759-772
24. Marx J. Drug development. Drugs inspired by a drug. Science 311 (2006) 322-325
25. McHugh D., Tanner C., Mechoulam R., Pertwee R.G., and Ross R.A. Inhibition of human neutrophil chemotaxis by endogenous cannabinoids and phytocannabinoids: evidence for a site distinct from CB1 and CB2. Mol. Pharmacol. 73 (2008) 441-450
26. Moir D., Rickert W.S., Levasseur G., Larose Y., Maertens R., White P., and Desjardins S. A comparison of mainstream and sidestream marijuana and tobacco cigarette smoke produced under two machine smoking conditions. Chem. Res. Toxicol. 21 (2007) 494-502
27. Moor A.N., Flynn J.M., Gottipati S., Giblin F.J., and Cammarata P.R. 17beta-estradiol stimulates MAPK signaling pathway in human lens epithelial cell cultures preventing collapse of mitochondrial membrane potential during acute oxidative stress. Mitochondrion 5 (2005) 235-247
28. Nilsson O., Fowler C.J., and Jacobsson S.O. The cannabinoid agonist WIN 55,212-2 inhibits TNF-alpha-induced neutrophil transmigration across ECV304 cells. Eur. J. Pharmacol. 547 (2006) 165-173
29. Novotny M., Merli F., Weisler D., Fencl M., and Saeed T. Fractionation and capillary gas chromatographic mass spectrometric characterization of the neutral components in marijuana and tobacco smoke concentrates. J. Chromatogr. 238 (1982) 141-150
30. Oh H.L., Seok J.Y., Kwon C.H., Kang S.K., and Kim Y.K. Role of MAPK in ceramide-induced cell death in primary cultured astrocytes from mouse embryonic brain. Neurotoxicology 27 (2006) 31-38
31. Pacher P., Batkai S., and Kunos G. The endocannabinoid system as an emerging target of pharmacotherapy. Pharmacol. Rev. 58 (2006) 389-462
32. Pertwee R.G. The pharmacology of cannabinoid receptors and their ligands: an overview. Int. J. Obes. (Lond) 30 Suppl 1 (2006) S13-18
33. Phillips R.J., Burdick M.D., Lutz M., Belperio J.A., Keane M.P., and Strieter R.M. The stromal derived factor-1/CXCL12-CXC chemokine receptor 4 biological axis in non-small cell lung cancer metastases. Am. J. Respir. Crit. Care Med. 167 (2003) 1676-1686
34. Phillips R.J., Mestas J., Gharaee-Kermani M., Burdick M.D., Sica A., Belperio J.A., Keane M.P., and Strieter R.M. Epidermal growth factor and hypoxia-induced expression of CXC chemokine receptor 4 on non-small cell lung cancer cells is regulated by the phosphatidylinositol 3-kinase/PTEN/AKT/mammalian target of rapamycin signaling pathway and activation of hypoxia inducible factor-1alpha. J. Biol. Chem. 280 (2005) 22473-22481
35. Portier M., Rinaldi-Carmona M., Pecceu F., Combes T., Poinot-Chazel C., Calandra B., Barth F., le Fur G., and Casellas P. SR 144528, an antagonist for the peripheral cannabinoid receptor that behaves as an inverse agonist. J. Pharmacol. Exp. Ther. 288 (1999) 582-589
36. Preet A., Ganju R.K., and Groopman J.E. Delta9-tetrahydrocannabinol inhibits epithelial growth factor-induced lung cancer cell migration in vitro as well as its growth and metastasis in vivo. Oncogene 27 (2008) 339-346
37. Puchelle E., Zahm J.M., Tournier J.M., and Coraux C. Airway epithelial repair, regeneration, and remodeling after injury in chronic obstructive pulmonary disease. Proc. Am. Thorac. Soc. 3 (2006) 726-733
38. Rennard S.I., Togo S., and Holz O. Cigarette smoke inhibits alveolar repair: a mechanism for the development of emphysema. Proc. Am. Thorac. Soc. 3 (2006) 703-708
39. Rinaldi-Carmona M., Barth F., Millan J., Derocq J.M., Casellas P., Congy C., Oustric D., Sarran M., Bouaboula M., Calandra B., Portier M., Shire D., Breliere J.C., and Le Fur G.L. SR 144528, the first potent and selective antagonist of the CB2 cannabinoid receptor. J. Pharmacol. Exp. Ther. 284 (1998) 644-650
40. Roth M.D., Arora A., Barsky S.H., Kleerup E.C., Simmons M., and Tashkin D.P. Airway inflammation in young marijuana and tobacco smokers. Am. J. Respir. Crit. Care Med. 157 (1998) 928-937
41. Roth M.D., Marques-Magallanes J.A., Yuan M., Sun W., Tashkin D.P., and Hankinson O. Induction and regulation of the carcinogen-metabolizing enzyme CYP1A1 by marijuana smoke and delta (9)-tetrahydrocannabinol. Am. J. Respir. Cell Mol. Biol. 24 (2001) 339-344
42. Sacerdote P., Massi P., Panerai A.E., and Parolaro D. In vivo and in vitro treatment with the synthetic cannabinoid CP55, 940 decreases the in vitro migration of macrophages in the rat: involvement of both CB1 and CB2 receptors. J. Neuroimmunol. 109 (2000) 155-163
43. Sarafian T.A., Tashkin D.P., and Roth M.D. Marijuana smoke and Delta(9)-tetrahydrocannabinol promote necrotic cell death but inhibit Fas-mediated apoptosis. Toxicol. Appl. Pharmacol. 174 (2001) 264-272
44. Sarafian T.A., Kouyoumjian S., Khoshaghideh F., Tashkin D.P., and Roth M.D. Delta 9-tetrahydrocannabinol disrupts mitochondrial function and cell energetics. Am. J. Physiol., Lung Cell. Mol. Physiol. 284 (2003) L298-306
45. Sarafian T., Habib N., Mao J.T., Tsu I.H., Yamamoto M.L., Hsu E., Tashkin D.P., and Roth M.D. Gene expression changes in human small airway epithelial cells exposed to Delta9-tetrahydrocannabinol. Toxicol. Lett. 158 (2005) 95-107
46. Sarafian T.A., Habib N., Oldham M., Seeram N., Lee R.P., Lin L., Tashkin D.P., and Roth M.D. Inhaled marijuana smoke disrupts mitochondrial energetics in pulmonary epithelial cells in vivo. Am. J. Physiol., Lung Cell. Mol. Physiol. 290 (2006) L1202-1209
47. Seamon M.J., Fass J.A., Maniscalco-Feichtl M., and Abu-Shraie N.A. Medical marijuana and the developing role of the pharmacist. Am. J. Health Syst. Pharm. 64 (2007) 1037-1044
48. Shahabuddin S., Ji R., Wang P., Brailoiu E., Dun N., Yang Y., Aksoy M.O., and Kelsen S.G. CXCR3 chemokine receptor-induced chemotaxis in human airway epithelial cells: role of p38 MAPK and PI3K signaling pathways. Am. J. Physiol., Cell Physiol. 291 (2006) C34-39
49. Shapira M., Gafni M., and Sarne Y. Long-term interactions between opioid and cannabinoid agonists at the cellular level: cross-desensitization and downregulation. Brain Res. 960 (2003) 190-200
50. Sidney S., Quesenberry Jr. C.P., Friedman G.D., and Tekawa I.S. Marijuana use and cancer incidence (California, United States). Cancer Causes Control 8 (1997) 722-728
51. Song Z.H., and Zhong M. CB1 cannabinoid receptor-mediated cell migration. J. Pharmacol. Exp. Ther. 294 (2000) 204-209
52. Stripecke R., Koya R.C., Ta H.Q., Kasahara N., and Levine A.M. The use of lentiviral vectors in gene therapy of leukemia: combinatorial gene delivery of immunomodulators into leukemia cells by state-of-the-art vectors. Blood Cells Mol. Dis. 31 (2003) 28-37
53. Tashkin D.P., Simmons M.S., Sherrill D.L., and Coulson A.H. Heavy habitual marijuana smoking does not cause an accelerated decline in FEV1 with age. Am. J. Respir. Crit. Care Med. 155 (1997) 141-148
54. Wang H., Liu X., Umino T., Skold C.M., Zhu Y., Kohyama T., Spurzem J.R., Romberger D.J., and Rennard S.I. Cigarette smoke inhibits human bronchial epithelial cell repair processes. Am. J. Respir. Cell Mol. Biol. 25 (2001) 772-779
55. Wu G.J., Tai Y.T., Chen T.L., Lin L.L., Ueng Y.F., and Chen R.M. Propofol specifically inhibits mitochondrial membrane potential but not complex I NADH dehydrogenase activity, thus reducing cellular ATP biosynthesis and migration of macrophages. Ann. N. Y. Acad. Sci. 1042 (2005) 168-176
56. Yuan M., Kiertscher S.M., Cheng Q., Zoumalan R., Tashkin D.P., and Roth M.D. Delta 9-tetrahydrocannabinol regulates Th1/Th2 cytokine balance in activated human T cells. J. Neuroimmunol. 133 (2002) 124-131
57. Zhang S., Zhou F., Ding J.H., Zhou X.Q., Sun X.L., and Hu G. ATP-sensitive potassium channel opener iptakalim protects against MPP-induced astrocytic apoptosis via mitochondria and mitogen-activated protein kinase signal pathways. J. Neurochem. 103 (2007) 569-579
58. Zhang Z.F., Morgenstern H., Spitz M.R., Tashkin D.P., Yu G.P., Marshall J.R., Hsu T.C., and Schantz S.P. Marijuana use and increased risk of squamous cell carcinoma of the head and neck. Cancer Epidemiol. Biomarkers Prev. 8 (1999) 1071-1078
59. Zhou Y., Wang Q., Mark Evers B., and Chung D.H. Oxidative stress-induced intestinal epithelial cell apoptosis is mediated by p38 MAPK. Biochem. Biophys. Res. Commun. 350 (2006) 860-865